Search…

Jinbo Biology: Intends to transfer 20% equity of its holding subsidiary to Ms. Hou Fang.

09/06/2026

Jinbo Biology Announcement, the company plans to transfer 20% equity of its subsidiary Taiyuan Jinhongyuan Research Medical Management Co., Ltd. to Ms. Hou Fang, with a transfer amount of 2 million RMB. Ms. Hou Fang is a related party of the company. After the transaction is completed, the company will no longer be the controlling shareholder of Jinhongyuan Research.

Latest

1 m ago

In the week leading up to June 6th, U.S. Redbook retail sales increased by 9.1% year-on-year, up from the previous value of 9%.

1 m ago

Bailing Biological's application for IPO on the ChiNext Board of the Shenzhen Stock Exchange has been accepted. It is the largest supplier of ursodeoxycholic acid raw materials in China.

2 m ago

Standard Chartered Bank's stock price fell by 3%, HSBC Holdings' stock price fell by 2%, while European bank stocks as a whole rose by 0.8%.

3 m ago

Executives of the Brazilian Aviation Industry Company stated that the grounding rate of E2 series aircraft has decreased to 1%, and the main engine issues have been resolved.

4 m ago

Zelensky: I met with the President of Finland and the Prime Minister of Norway, and briefed them on the high-level communication between Ukraine and the trilateral group, as well as the United States.

See all latest